09 Jan

Dublin medtech HealthBeacon raises $12m in a Series A round

With funding and FDA clearance under its belt, this Dublin tech start-up has plans to help patients stick to their medication schedule.

(Dublin, Ireland; San Francisco, CA – January 8th, 2019) Dublin and Boston based digital health company, HealthBeacon announces the completion of its Series A investment round of $12M, bringing total funding to date into the company of $15M. The announcement was made in San Francisco, CA at the JP Morgan Chase Biotech Showcase. The funding comes on the back of rapid global expansion of its FDA cleared HealthBeacon Smart Sharps Technology. 

 The funding from this Series A will be used to launch its Smart Sharps System into the USA and to develop out their portfolio of medical adherence tools for high value medications. The addressable market for injectable medications has reached nearly $50 billion. As of today, HealthBeacon operates in 10 markets and has tracked more than 200,000 home based injections making it one of the largest global deployments of a medical adherence device. Today HealthBeacon employs over 30 people and plans to double the team over the next 18 months.

 The smart sharps bin system by HealthBeacon has made it easier for patients, using injectable medications, to stay on track with their treatment schedule. This has resulted in improved patient medication adherence and driving patient care. In December, they were awarded eHealth Innovation of the Year, by the MedTech Association of Ireland. 

Doug Veale, Professor of Rheumatology, St Vincent’s Hospital Ireland “I’ve been using the HealthBeacon for over two years and their Smart Sharps Bin has had a profound impact on how patients manage their treatment. I know with confidence as to whether my patients are adhering to their treatment strategy.” 

The round was organized by HealthBeacon and Cantor Fitzgerald and led by Oyster Capital and Elkstone Partners, the investment syndicate included Quorndon Capital and Cantor Fitzgerald’s Private Client Group. Previous investors in HealthBeacon include Enterprise Ireland, BVP and a range of Angel Investors. 

Liam Kiely, Director, Cantor Fitzgerald said “We are delighted to have worked with HealthBeacon in putting this $12m Series A round together. Cantor has a major focus on Life Sciences and on Digital Health, and we have every confidence that CEO & co-founder Mr. Jim Joyce has created a true sector leader in HealthBeacon.”

This fundraise was covered by the Silicon Republic and NewsTalk Business Breakfast.


20 Dec

HealthBeacon Presents at JP Morgan Digital Medicine and Medtech Showcase

Digital Health company, HealthBeacon, will present for the third time at the 11thAnnual JP Morgan Conference in San Francisco, CA. HealthBeacon CEO, Jim Joyce will present at the Digital Medicine and Medtech Showcase to the biggest names in medical technology. The conference takes place on January 7th– 10that the Parc 55 San Francisco hotel.

HealthBeacon’s presentation time and venue:

Digital Medicine & Medtech Showcase on Tuesday, January 8th , 2018 at the hotel Parc 55 San Francisco at 1:30 pm (PST) – Powell – I (Level 3).

Parc 55 San Francisco – Union Square

55 Cyril Magnin Street, 3rd Floor

San Francisco, CA 94102

About HealthBeacon

HealthBeacon is a Digital Health company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

07 Dec

HealthBeacon Wins eHealth Innovation of the Year

Digital Therapeutic company, HealthBeacon Wins eHealth Innovation of the Year at the Irish Medtech Awards.

HealthBeacon was honoured last night as the eHealth Innovation of the Year at the Irish MedTech Awards. This award is to recognise the integration of ICT in the world of healthcare and rewards the best eHealth/ mHealth solutions produced by the eHealth sector. This award was presented by John Shiel , Senior Development Advisor, Life Sciences Dept, Enterprise Ireland and was received by Kieran Daly, CTO and Joyce Power, Quality Manager.

This award caps a successful 2018 for HealthBeacon that includes achieving FDA clearance, a doubling of markets served, as well as multiple industry awards in Europe and North America.

The evening’s winners were revealed at a black tie gala evening where the best of Ireland’s medtech industry were recognized and celebrated in front of hundreds of senior executives.

In addition, HealthBeacon was invited to attend the two-day Medtech Rising: CEO Conference and Awards, as well as, an opportunity to host a stand at Medtech Rising which is attended by 500 professionals.

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

27 Nov

Vodafone teams with HealthBeacon for patient medication tool

Device developed by digital therapeutics company reminds patients about injections

Vodafone Ireland has teamed up with Irish digital therapeutics company HealthBeacon to provide internet of things (IoT) connectivity for the company’s new smart health product.

HealthBeacon, which is headquartered in Dublin, develops smart tools for managing medication. Its latest product helps to remind patients to inject their medications at home. The device can be programmed with a patient’s medication schedule, and will remind them to take it at the correct times.

Vodafone IoT connectivity will connect the devices and facilitate the transfer of data. “This enables HealthBeacon to streamline our expansion and launch new countries quickly,” said Kieran Daly, HealthBeacon co-founder chief technical officer. “This global partnership will serve patients all over the world and ensure seamless connectivity for both our current and next-generation devices.”

“Remote patient monitoring is one element that empowers people to manage their conditions and helps them to live more independently,” said Debbie Power, Vodafone Ireland’s IoT country manager. “Our next-generation network means we are at the forefront of ensuring healthcare is securely connected now and into the future.”

Featured in:

Irish Times: https://www.irishtimes.com/business/technology/vodafone-teams-with-healthbeacon-for-patient-medication-tool-1.3711371

Silicon Republic: https://www.siliconrepublic.com/machines/healthbeacon-vodafone-medtech-iot-roll-out

14 Nov

HealthBeacon signs agreement with Canada’s leading patient support provider, Innomar Strategies

HealthBeacon, partners with Innomar Strategies, to bring its smart sharps bin offering to Canada.

(DUBLIN, IE., TORONTO, ON. –November 14th, 2018) HealthBeacon announced today their partnership with Innomar Strategies to provide the HealthBeacon smart sharps bin and digital therapeutic platform to Canadian patients across the country.

HealthBeacon is a Dublin headquartered, digital therapeutic company that produces a smart sharps bin to track and drive medication adherence. Following their recent FDA clearance in the US, HealthBeacon has begun investing resources in the North American markets of the United States and Canada. Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market, helping patients navigate the complicated Canadian healthcare system, and providing support for their injections and infusions.

“We have seen great patient engagement with the HealthBeacon tool in Ireland. It has been instrumental in aiding us in identifying patients that need assistance, and helping drive adherence to their medication. I’m delighted to see they are making HealthBeacon available in Canada.” – Dr. Trevor Duffy, Rheumatologist

HealthBeacon began operations in Canada with the opening of their Montreal office in December 2016. HealthBeacon CEO, Jim Joyce commented, The Canadian market is a large market, both geographically and in terms of patients who could benefit from our technology. The signing of this partnership is a major milestone in making our technology accessible to the Canadian market.

As an industry leader, Innomar deeply understands the patient journey.  A core focus is delivering best-in-class care and education through patient services to monitor adherence and ensure optimal outcomes.

“We look forward to partnering with HealthBeacon as they move into the Canadian market.  Our focus is on patient care, and having a tool to track and facilitate medication adherence brings value to patient care across Canada,” says Amar Pabla, Vice President Nursing, Clinics and Pharmacovigilance.

“HealthBeacon are a fantastic example of Irish innovation. This partnership is testimony to the deepening links between Irish and Canadian healthcare. As the government agency driving the growth of Irish businesses internationally, we at Enterprise Ireland look forward to seeing HealthBeacon support Innomar Strategies in its mission to advance patient support across Canada.” – Neil Cooney, Country Manager Canada, Enterprise Ireland

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. The HealthBeacon is a smart sharps bin for patients who self-inject medications at home. It is digitally connected and programmed with a patient’s personal medication schedule, and uses customized reminders to help them start and stay on track with medication. The company is headquartered in Dublin, Ireland and has offices in the US and in Canada. Learn more at www.healthbeacon.com

About Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment tobest-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomarstrategies.com.

31 Oct

HealthBeacon Builds Presence in Asia

HealthBeacon started off in Ireland piloting its technology with the local Irish divisions of pharmaceutical giants. These same great clients networked us into their global organisation which led to deployment of our HealthBeacon Medication Management technology across 10 Countries: USA, Canada, across the EU, South Africa, Baltics, Brazil, Israel and South Africa. We had to develop global organisational muscles early in our life, our clients made it a prerequisite. Now we are heading to Asia!

We will be featured on two panels at large Digital Health events in both Mumbai and Singapore.

The first will be a global gathering for HealthXL presented by Abbott and featuring panelists and speakers that include Arun Kumar, Head of South Asia for Bayer and Dr Arvind Sivaramakrishnan, Chief Information Officer at Apollo Hospitals

The second event is a panel about Digitising Patient Care featuring Jim Joyce, Everett Leonidas from Aviva Ventures which will be moderated by Susanna Hasenoehrl of Joice Nutrition and hosted by SG Innovate in Singapore.

In collaboration with these two great organisations, HealthXL and SG Innovate, we will begin  introducing ourselves and our technology into the Singapore, Australian and Indian markets. These three markets will become our first wave of Asia-Pac HealthBeacon deployments.

Operating a young technology company across 10 countries from our two office locations,  Dublin and Boston required us to leverage scaling technology platforms, find excellent local partners, build scalable roll-out processes that are all driven by a team that thinks globally.


HealthXL Global Gathering Mumbai

Date/Venue: 1st November 2018, 9:00am- 4:00pm

Bandra Kurla Complex Mumbai


  • Patient Centricity
  • Non-Communicable DiseaseDigital
  • Health Investments in India
  • Big Data to Improve Patient Outcomes




Digitising Patient Care- SG Innovate

Date/ Venue: 8th November 2018, 5:00pm- 7:00pm

32 Carpenter Street, Singapore 059911

In the midst of a patient data revolution, this panel will discuss the importance of caring for and facilitating patient data in a way that makes sense. Medtech and digital therapeutics are increasingly focused on patient centricity and care. Our leading experts will be focused on providing a vision for the future of patient care in a digital world.



25 Oct

HealthBeacon Sponsors Ireland’s Cancer Fund for Children

HealthBeacon will be supporting the Cancer Fund for Children as the “Speakeasy” Sponsor at this years’ Gala Ball. The Gala Ball is part of a 5-year program that aims to raise €1m for the Cancer Fund for Children. They are in large part supported by Ireland’s Digital Economy with its inaugural 2017 Gala Ball raising more than €137,000. The goal is to build a brand new therapeutic centre for children diagnosed with cancer, and their families, in Ireland.

Cancer Fund for Children has been supporting families for over forty years. They offer practical, emotional and financial help and also include stress-relieving, nurturing breaks at their therapeutic centre Daisy Lodge in County Down. Unfortunately, the overwhelming need has the centre operating at full capacity and created a long wait list for families.

This fundraising program will bring Daisy Lodge Connacht to the west of Ireland. This worthy project is supported by prominent Irish citizens such as professional golfer Rory McIlroy and will be attended by over 300 people including Paul Harrington, Bobby Kerr, Holly Carpenter and Eddie Irvine.

“HealthBeacon is delighted to be sponsoring this great event and worthy cause. The Cancer Fund for Children has ambitious plans for their new therapeutic centre in Mayo. This site will be entirely dedicated to support children and their families that have been diagnosed with cancer.” Jim Joyce, CEO HealthBeacon

For more information on the project, please see https://cancerfundforchildren.com/event/great-gatsby-gala-ball/

24 Oct

HealthBeacon attends Johnson & Johnson, JLABS CEO Summit

HealthBeacon are delighted to attend the 2nd annual JLABs CEO Summit in sunny La Jolla, San Diego. 

The event has gathered partners of Johnson & Johnson’s, JLABs group for two days of networking and information exchange as well as talks and panel discussions with industry leaders. 

HealthBeacon has been part of the global JLABs network after being chosen as the winner of the Johnson & Johnson Innovation, JLABS and Janssen Supply Chain Group, LLC (JSC) Patient Adherence QuickFire Challenge earlier this year.

Since winning the QuickFire Challenge, HealthBeacon has achieved FDA clearance for it’s smart sharps bin and launched in an additional four markets including the U.S. so there is a lot to catch up on with old friends and new at the event. 

This coupled with the growth of our product portfolio and data analytics platform offers a clear point of intersection within the JLABs ecosystem.

Having completed day one of the event which was focussed on JPAL & Investor Partnering we are excited to partake in the CEO Summit main program which began tonight featuring talks from J&J executives, JLABS CEOs, investors and industry leaders, and continues on Wednesday 24th.


10 Oct

HealthBeacon appoints Alan Dalton, Senior Manager of Contracts and Reimbursement

HealthBeacon today announced that Alan Dalton, formerly of VHI, Ireland’s largest private health insurer, has joined the HealthBeacon team as the senior manager of contracts and reimbursement.  Alan brings expert experience in both new businesses contracting and private health insurance reimbursement.

In his time with VHI, he negotiated contracts with hospital providers and medical device companies and supported the corporate proposition strategy team in VHI. Part of his role also included managing and driving the VHI service projects within the medical division and working closely with stakeholders of product development, marketing, legal, IT and finance.

Prior to his work with VHI, Alan spent over two years in Sydney working with the Evolution Healthcare Group, a private hospital operator in Australia and New Zealand, where he worked alongside the Executive Chairman in negotiating and developing agreements with device and pharma companies to drive value for the Evolution Group.

In his role, Alan will develop and introduce reimbursement models for both existing and new markets working alongside pharmaceutical and healthcare clients.

HealthBeacon is delighted to have Alan join the team and we look forward to the expertise he brings to our clients and partners.

27 Sep

HealthBeacon Opens New Production Facility


Today, Wednesday 26th September, Minister of State for Mental Health and Older People Jim Daly T.D. joined Irish digital health technology company HealthBeacon, to celebrate the official opening of their newly expanded Irish headquarters in Dublin 12.

HealthBeacon has been on an upward trajectory since founding in 2014, with 2018 their busiest year yet. Over the past four years the innovative Irish medtech company has experienced comprehensive market penetration within Ireland, witnessing in excess of 100% market growth.  HealthBeacon has doubled staffing over the last 18 months, now employing 30.  With offices in Ireland, Canada and the US, the business operates across 10 markets from the Headquarters in Dublin. The company was recently granted FDA (US Food and Drugs Administration) clearance and launched into the US market, which is worth hundreds of millions of dollars.

HealthBeacon develops smart tools for managing medication. The ‘Smart Sharps bin”, designed for injectable medication management, tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. The stand-alone device is bringing medtech into the ‘heart of the home’ helping to address one of the biggest unmet needs within the health arena – tracking patient’s real time usage and supporting chronic medicine schedules are maintained.

The expansion of HealthBeacon HQ makes way for advanced manufacturing processes and accommodate their growing data science team. The ground-breaking Irish company growth has been driven by global demand from the pharmaceutical industry and as such is increasing the technical capacity, customer care, warehouse and manufacturing space for both the production and the product development teams.

Speaking at the event, Jim Joyce, CEO of HealthBeacon added;

2018 has been a fast track year for HealthBeacon and today reflects our successes and our ongoing continued investment here in Ireland, our global HQ. The company has entered multiple new markets this year and received FDA clearance allowing us to enter the US market, with the world’s only Smart Sharps Adherence Platform. Looking forward, we are committed to continuing contributing to Ireland’s reputation as a global leader offering innovative best in class healthcare solutions.

The HealthBeacon system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into thousands of patients homes throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

HealthBeacon have worked closely with Enterprise Ireland since founding and were joined by Terence O’Rourke, Chairman, Enterprise Ireland today:

I am delighted to be at the opening of the HealthBeacon expanded production facility to support the company’s growth activities.  Working closely with Enterprise Ireland since 2014, HealthBeacon is designing and developing digital tools that impact positively on the lives of patients worldwide.

 The thriving Irish medtech sector continues its story of success and the development of innovative products such as the Smart Sharp Bin contribute significantly to Ireland’s reputation as a global leader in healthcare solutions. Our aim at Enterprise Ireland is to help businesses with global ambition to build scale and expand reach, and we will continue to work with HealthBeacon as it delivers medical solutions through innovation, underpinning the company’s continued growth in world markets.”

The opening event was attended by leaders from; medtech sector, executives from healthcare, pharmaceuticals, technology and finance.

Speaking before the launch, Minister for Health Simon Harris TD said; “Health research and innovation are an integral part of a well- functioning health service. Medical progress is directly linked to a strong health research community. We recognise that health research is a key factor in promoting the health of the population, combating disease, reducing disability and improving the quality of care. It can and does improve the quality of our health services and the quality of life of many in our society. It can do this by utilising research-led preventative strategies and deployment of services; by bringing the latest treatments to patients; by developing new models of care, and improving the efficiency and effectiveness of health care delivery.” 

Keynote speakers at the event who provided expertise on scaling healthcare technology companies in Ireland, included; Jim Joyce, CEO of HealthBeacon, Terence O’Rourke, Chairman of Enterprise Ireland, and Orla O’Gorman, Head of Equity Listing Ireland, EURONEXT.

© 2015 Health Beacon - Privacy Policy - Website by Medusa